CD16a Proteins, Antibodies, cDNA Clones Research Reagents

All CD16a reagents are produced in house and quality controlled, including 16 CD16a Antibody, 18 CD16a Gene, 1 CD16a IP Kit, 7 CD16a Lysate, 10 CD16a Protein, 2 CD16a qPCR. All CD16a reagents are ready to use.

CD16a Protein (10)

    CD16a Antibody (16)

      CD16a cDNA Clone (18)

      NM_001127593.1

      In cloning vector

      In expression vector

      In lentiviral vector

      NM_207603.1

      CD16a qPCR Primer (2)

      CD16a Lysate (7)

        More Product Popular With Customers

        CD16a Background

        The Fc receptor with low affinity for IgG (FCGR3, or CD16) is encoded by 2 nearly identical genes, FCGR3A and FCGR3B, resulting in tissue-specific expression of alternative membrane-anchored isoforms. FCGR3A, it is also known as CD16a, encodes a transmembrane protein expressed on activated monocytes/macrophages, natural killer (NK) cells, and a subset of T cells. CD16a / FCGR3A is a receptor expressed on NK cells that facilitates antibody dependent cellular cytotoxicity (ADCC) by binding to the Fc portion of various antibodies. CD16a / FCGR3A also has a broader function. CD16a / FCGR3A is directly involved in the lysis of some virus-infected cells and tumor cells by NK cells, independent of antibody binding. Cross-linking of CD16a / FCGR3A on NK cells resulted in increased intracellular Ca2+ levels and a cascade of biochemical events similar to those activated by the T cell receptor. CD16a / FCGR3A on human NK cells is a lysis receptor that mediates the direct killing of some virus infected and tumor cells, independent of antibody ligation.

        CD16a References

        • David Dornan, et al. Effect of FCGR2A and FCGR3A variants on CLL outcome. Blood. 2010 116: 4212-4222

        Note: Flag® is a registered trademark of Sigma Aldrich Biotechnology LP. It is used here for informational purposes only.